CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Study of Sequestered Transscleral, Controlled-Release Dexamethasone Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or Vitreous

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04120311
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:27.779154+00:00
Published At: 2023-11-24T00:00:00+00:00
Record Updated At: 2023-11-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Macular Edema", "Radiation Retinopathy", "Branch Retinal Vein Occlusion", "Epiretinal Membrane", "Central Serous Retinopathy With Pit of Optic Disc", "Commotio Retinae", "Vitritis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-11-24"
protocolSection.identificationModule.nctId: "NCT04120311"
protocolSection.identificationModule.officialTitle: "Phase I Study of Sequestered Transscleral, Controlled-Release Dexamethasone Delivered Via Episcleral Reservoir for Treatment of Macular Edema \u0026 Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or Vitreous"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.